Ozempic-fueled slimming is blowing up the wedding dress industry

France Nouvelles Nouvelles

Ozempic-fueled slimming is blowing up the wedding dress industry
France Dernières Nouvelles,France Actualités
  • 📰 cnni
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 59%

Price distortions and dysfunction are nothing new in the $73 billion wedding industry. But the explosion of weight-loss drugs in the 2020s has created an extra snag for the seamstresses and designers responsible for the Big Day’s centerpiece garment: the bridal gown.

The Hollywood weight-loss secret is out, and it’s more accessible than ever. GLP-1 drugs, known by brand names Ozempic and Wegovy, have become widely available, in part through compounding pharmacies that offer cheaper, non-FDA-approved versions. And, as my colleague Tami Luhby reported this week, demand for these drugs is set to grow even more as employers increasingly consider covering them for weight loss — not just diabetes.

While most gowns can be taken in several inches, there are limits, and brides who experience extreme weight loss could end up needing to purchase a new dress entirely. The average bridal gown retailed for $2,000 in 2023, according to the Knot. That’s before alterations, which can tack on hundreds or even thousands to the bill. The biggest loser The Ozempic effect is also stressing out seamstresses.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

cnni /  🏆 326. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Bitcoin Price Analysis: Will It Reach $73-79K?Bitcoin Price Analysis: Will It Reach $73-79K?This technical analysis explores the potential price trajectory of Bitcoin, focusing on an Ending Diagonal pattern. The analyst predicts a bullish scenario with a target around $65K, followed by a pullback and a final surge towards $73-79K. However, alternative scenarios involving a lower low are also discussed.
Lire la suite »

Ozempic ‘very likely’ to see prices slashed in drug price negotiationsOzempic ‘very likely’ to see prices slashed in drug price negotiationsThe ability to negotiate drug prices is part of a sweeping set of policies in President Joe Biden’s Inflation Reduction Act.
Lire la suite »

Novo Nordisk CEO Defends Ozempic Price In Senate TestimonyNovo Nordisk CEO Defends Ozempic Price In Senate TestimonyTy Roush is a New York City-based breaking news reporter who frequently covers Russia’s invasion of Ukraine, the automotive industry and sports money. He joined Forbes in 2022 and has covered Exxon acquiring Pioneer for nearly $60 billion, a mysterious respiratory illness affecting dogs across the U.S.
Lire la suite »

Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugsBernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugsSen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Lire la suite »

The maker of Wegovy and Ozempic will testify about the price of the drugsThe maker of Wegovy and Ozempic will testify about the price of the drugsLawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can range from $0 a month to over $1,000 if it isn't covered.
Lire la suite »

Novo Nordisk CEO Grilled by Congress Over Price of OzempicNovo Nordisk CEO Grilled by Congress Over Price of OzempicDuring a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jorgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.
Lire la suite »



Render Time: 2025-02-23 21:22:49